EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2021 |
| Reihe/Periodikum: | Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069 |
| Verlag/Hrsg.: |
Wiley
|
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-28874070 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | http://dx.doi.org/10.1002/hon.20_2881 |
